© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
DOPE's journey traces back to the expansion of lipid biochemistry through the twentieth century. As scientists explored the makeup of biological membranes, they discovered phospholipids do a lot more than just form barriers in cells. I remember reading about early experiments that separated lipids from egg yolks and tissues, which led to the identification of compounds like DOPE. Through the decades, researchers pieced together the structure of this molecule, recognizing its two oleoyl chains linked to a glycerol backbone with a phosphoethanolamine headgroup. Lipids like DOPE highlight how careful observation and patient research gradually map out the molecules shaping life’s processes. Progress in chromatography, mass spectrometry, and NMR pushed the understanding of complex lipids further, putting DOPE on the radar for both academic study and practical use. These advances now support innovations across biomedicine and materials science.
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine belongs to the phosphatidylethanolamine class. Fatty acids with double bonds make up its core, so it doesn’t pack as tightly as saturated versions. I first came across DOPE in a lab course focused on membrane models, where it provided an ingredient for building more realistic cell analogs. The presence of DOPE helps mimic how real membranes behave, giving that right mix of flexibility and fluidity. Beyond lab benches, DOPE acts as a helper in drug delivery, gene transfer, and even synthetic biology. It brings structural variety and supports the dynamic changes that natural membranes need during activities like cell signaling. DOPE often goes by several names—just to confuse anyone picking up a journal paper. You’ll see it as dioleoyl PE, or sometimes under proprietary code names sold for research or pharmaceutical use.
Two unsaturated oleic acid tails define DOPE’s character. This unsaturation bends each tail, which keeps molecules apart and boosts membrane fluidity. Unlike certain phospholipids, DOPE prefers forming non-lamellar, hexagonal phases under specific conditions. I recall how its lower transition temperature could mess with otherwise simple membrane experiments. Researchers lean on these phase changes, especially because these shifts support membrane fusion events. The actual appearance of DOPE lands in the yellowish, waxy range; it dissolves in common organic solvents but mostly resists water. Handling pure DOPE requires tight temperature control, protecting it from oxidation, and keeping containers tightly sealed. Its zwitterionic headgroup lets it interact with different molecules, making it versatile for blending in custom lipid concoctions.
DOPE usually comes with standardized labeling that tells you its purity, often running higher than 99 percent for research use. Producers disclose information on chemical structure, stereochemistry, fatty acid content, and common contaminants. Knowledge of this fine print came in handy during projects where contamination from storage bottles would actually change experimental results enough to throw off the data. You’ll find molecular weight listed around 744.1 g/mol, with chemical identifiers from various international agencies, but labeling in practice focuses on helping buyers trace the origin and processing of batches. Quality control steps include checks for peroxides and residual solvents. Still, even with pristine handling, long-term storage under nitrogen or argon makes a real difference. Anyone using DOPE in delicate studies or formulations must take fresh batch records seriously—skipping this step risks ruining sensitive cell culture work.
DOPE can be prepared via both chemical and enzymatic methods. One practical lab route starts with glycerol and sequentially adds each fatty acid chain by using activating agents, then attaches the phosphoethanolamine group in a final coupling step. This multi-step process highlights why synthetic lipids command a premium price—each reaction needs purification and analytical checks. Chemical synthesis allows for customization, so researchers sometimes swap fatty acids or head groups to tune the properties for special experiments. Enzymatic approaches use natural or engineered enzymes to pick the right stereochemistry, as the stereopurity can impact physical and biological behavior. Labs working on modified vesicles often buy specialty DOPE versions with linkers or fluorescent tags, designed for imaging or conjugation. Reactive sites, like the amine in the ethanolamine part, offer convenient handles for adding further functional groups or labels. The drive for precision and reproducibility has turned lipid synthesis into an interdisciplinary effort involving organic chemists, biochemists, and even engineers developing automated systems.
DOPE's chemistry lends itself to transformation. The two double bonds on its oleoyl chains draw interest for selective oxidation or addition reactions, which help introduce new functionality. Modifications to the headgroup or acyl chains open up more options, letting researchers design lipids with tailored responsiveness or stability. More than once, I’ve seen colleagues create DOPE derivatives carrying targeting molecules, dyes, or cleavable linkers that react to specific triggers like pH or light. These tailored lipids spark creative solutions, especially in targeted delivery for drugs or nucleic acids. On the other hand, modifying the molecule too much can compromise its natural membrane behavior, leading to aggregation or loss of function in living systems. This balancing act between custom chemistry and biological relevance drives much of today’s innovation in lipid research.
Those new to working with DOPE tend to overlook how organic solvents and oxidation products can complicate lab routines. Safety best practices mean avoiding breathing in fine powders, wearing gloves, and using chemical hoods when redisolving or manipulating the lipid. Companies selling DOPE disclose recommended storage—typically cool, dark, and anoxic—and often package under inert gas. Spills may leave sticky residues, which need scrubbing with proper cleaners to avoid stubborn contamination. As with many unsaturated lipids, improper storage allows oxidative degradation, leading to the buildup of irritants or toxic byproducts. Rigorous safety reviews and audits help keep routine slip-ups from becoming accidents. Some teams use lipid stocks in single-use aliquots to dodge problems, and it’s a lesson I picked up after seeing one batch of oxidized lipids ruin an entire week’s worth of cell culture data.
In the real world, DOPE finds itself at the crossroads of cutting-edge drug delivery and biotechnology. Pharmaceutical teams working on gene therapy rely on DOPE’s fusogenic properties to get drugs and genes into hard-to-reach cells. It plays a central role in forming liposomes and lipid nanoparticles that carry vaccines, cancer drugs, or RNA therapeutics. I’ve watched graduate students mix up simple liposome batches on the bench, using just DOPE and cholesterol, then adapt these recipes for more complex needs. Biophysicists use DOPE-rich vesicles to study membrane fusion and curvature. Its unique phase behavior provides insights into viral entry and cellular processes. Even outside the lab, DOPE appears in advanced food packaging and biosensor applications, adding a bio-inspired layer of function to otherwise traditional technologies.
Every research conference brings new twists on using DOPE. Investigation keeps growing around how it manages cellular barriers or improves safety and effectiveness in delivery systems. Teams worldwide are figuring out how subtle chemical tweaks reshape its performance. In my own work, projects involving siRNA delivery or antigen presentation have shown DOPE can dramatically shift biological outcomes, just by adjusting relative ratios with other lipids. Structural biologists exploit its phase behavior to mimic natural environments for membrane proteins. Many studies dig into DOPE's role in immune response, cell signaling, and the fate of various nanomedicines. Machine learning now promises to speed up the design and selection of lipid blends, and DOPE stays central to these explorations.
Toxicity research around DOPE stays intense, mostly because any ingredient in drug carriers needs to be as safe as possible. Extensive animal studies rank phosphatidylethanolamines like DOPE as low in toxicity, especially compared to synthetic cationic lipids. Still, repeated exposure to large amounts, especially in vulnerable tissue, can produce inflammatory responses or disrupt cell membranes. Oxidative breakdown products pose the main risk—they’ve been linked to unwanted immune effects or membrane destabilization in sensitive cells. Most labs and companies rely on published in vivo profiles and strict ingredient controls to minimize risk. I once came across a trial halted midstream because uncontrolled DOPE oxidation threw off both the therapeutic response and basic safety metrics. Regulators continue to refine standards for lipids in clinical use, insisting on pure, fresh, and rigorously characterized ingredients for experimental medicines.
Interest in DOPE shows no signs of slowing. Lipid nanoparticle technology keeps gaining traction, and DOPE remains a go-to choice for fusion and delivery platforms. Improved synthetic methods promise more sophisticated DOPE derivatives tailored to individual patient or molecular needs. Researchers continue to explore its role in mimicking the crowded, curved membranes found in real organs. Developments in green chemistry and sustainable sourcing address calls for cleaner production in the industry. For those of us on the research side, the lure isn’t just academic—watching DOPE’s impact stretch from bench to bedside, powering the delivery of next-generation medicines and vaccines, delivers practical rewards and keeps the field hungry for more knowledge.
Research labs and biotech companies talk about 1,2-Dioleoyl-sn-glycero-3-phosphoethanolamine, or DOPE, with real respect. It shapes the structure of lipid nanoparticles. These nanoparticles protect fragile drugs like mRNA, guiding them to the right cells. That’s not some sci-fi notion—DOPE showed up in many vaccine efforts during the pandemic. Without it, many of those shots never would have reached patients.
Think of DOPE as a team player among other lipids, each with a different job. DOPE supports “fusogenic” activity—the ability of particles to fuse with cell walls. In plain talk, it helps drug payloads cross the tough outer membranes that protect our cells. Take lipid nanoparticles carrying genetic material: DOPE changes shape in specific environments inside the body. This temporary change nudges the medicine to spill out at exactly the right moment.
Lab researchers have watched how DOPE acts under different conditions. Mix it with other helper molecules and it boosts uptake in cell cultures. Clinical reports confirm this: higher rates of gene delivery translate into stronger activity in patients. Scientists lean heavily on these results to design new therapies. The current excitement around RNA-based drugs and vaccines has a lot to do with the mechanics DOPE provides.
People rarely hear about what makes life-saving treatments possible. The chemicals that hold mRNA together or keep it stable in a shot almost never get a headline. Still, the benefits touch nearly everyone’s life. mRNA vaccines didn’t pop out of nowhere—they’re the result of years spent understanding small details, like how DOPE folds, moves, and reacts.
It tells us that medicines are not just about the active ingredient. The “messenger” that carries that ingredient and gets it working in the body is a story of its own. DOPE has been a quiet hero in this science. Kids and adults who avoided severe illness thanks to mRNA vaccines owe something to this molecule.
Relying on molecules like DOPE brings its own headaches. Sourcing high-purity synthetic lipids is never cheap. Each batch must pass strict quality tests, and setbacks happen. Health agencies demand rigorous safety checks since these particles travel deep inside the body. Some scientists worry about environmental and long-term health effects, especially when scaling up to supply millions of doses.
Those in the field have pushed for greener chemical processes and better traceability. There’s big interest in developing alternatives that keep the strengths of DOPE—flexibility and cell entry—while reducing potential risks. The science community compares every new lipid carrier to DOPE’s solid track record.
One molecule doesn’t solve global health issues, but DOPE plays a role in the big shift toward personalized, targeted treatments. Behind every elegant new therapy sits years of effort building safe, reliable delivery systems. I’ve followed these developments in the lab and through patient stories, and the lessons stick: careful chemistry enables real breakthroughs. As new therapies emerge, DOPE’s influence shows how small innovations in materials science can charge ahead and change millions of lives.
Most folks who work with delicate chemicals learn quickly that storage is half the battle. 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, or DOPE, pops up in many biochemical and pharmaceutical labs. DOPE forms the backbone of plenty of lipid research and takes center stage in some cutting-edge drug delivery projects. It's known for its tricky storage requirements, and a slip here can ruin days or weeks of hard work.
DOPE starts breaking down when exposed to heat or bright light. Its unsaturated bonds react with oxygen and start turning rancid, losing their effectiveness and changing how they behave in experiments. This is not just theory—countless scientists have tossed out ruined batches. The difference between DOPE that’s been kept cool and dark versus one out on a bench all week shows up in unreliable data and budget headaches.
If you ask any senior scientist, there’s often a story about a student or tech who grabbed a bottle from a refrigerator with an aging compressor or left a vial on a bench under fluorescent lamps. That batch changes color, starts smelling odd, or, if put to the test, delivers scattered data no one can explain. DOPE typically wants temperatures below -20°C to keep peroxidation at bay. Even in the fridge, not all cold storage setups deliver. Many compressors in older labs can’t hit lower temperatures consistently—I've seen folks resort to dry ice boxes during power outages rather than risk losing their last bit of DOPE.
Oxygen spells trouble for DOPE. Open and close a bottle just a few times at room air and you invite oxidation. The same goes for humidity—water degrades the lipid and turns pure powder into a pasty mess. Using an inert gas like nitrogen or argon to flush bottles keeps the air and water out. I remember one lab mate who always topped off open bottles with nitrogen before sealing them. That simple step translated to fewer failed experiments in our group.
Manufacturers ship most high-purity lipid powders in tightly sealed, dark glass bottles or metal containers. Researchers crack those open only in low-moisture rooms with dedicated desiccant packs around. Even then, the smart ones split the main stock into several small aliquots. This practice stops repeated freeze-thaw cycles that introduce condensation and temperature shocks. Each time a frozen bottle thaws and refreezes, the molecular structure shifts just enough to throw a wrench into sensitive studies on membrane behavior or nanoparticle assembly.
Training new lab members usually starts with a talk about proper storage. Keep DOPE away from direct sun, work in low-light rooms when possible, and always keep containers tightly closed after withdrawing the needed amount. Mark opening dates and discard bottles that stay around too long or change color. Regularly check freezer temperatures with a separate logbook—not just reading the outside panel, as faulty thermometers fool plenty of people.
Some groups use small ultra-low freezers dedicated only to their supply of fragile lipids. This may sound like overkill, but for labs depending on reproducible liposome synthesis, it pays off. Drying agents like silica packets or molecular sieves near storage areas can stave off accidental moisture build-up.
Careful handling of DOPE boils down to respect for time, money, and effort. Following solid, science-backed routines keeps research reliable, prevents waste, and lets people focus on making discoveries instead of solving avoidable storage messes.
Most people outside certain scientific circles haven’t heard about DOPE—short for dioleoylphosphatidylethanolamine. Many know it from cell biology or pharmaceutical work, where it plays a role in cell membranes and drug delivery. The rules of chemistry don’t change just because you swap the lab coat for street clothes: solubility matters, and it matters for safety, bioavailability, and design decisions.
DOPE has a structure that reminds me of trying to oil a squeaky hinge with butter. It comes with a bulky tail—two long chains of fatty acids. This kind of structure prefers cozying up to other greasy molecules. Drop it in water, and there’s a clear disconnect. Water loves hydrogen bonding—charged ends seek out charged ends. DOPE lacks those opportunities: it’s not keen on dissolving or dispersing in water unless you add help, like sonication or detergents.
Science keeps proving this point. Extensive data shows that DOPE, much like other phospholipids, practically refuses to dissolve in water at room temperature. Add it to a beaker of water and you get large clumps or cloudy suspensions. That’s more bad news than good for anyone hoping to use water as a solvent.
Try pouring olive oil into a glass of ethanol. You see how easily things mix—it’s the same logic for DOPE. Organic solvents like chloroform, ethanol, or methanol provide “like dissolves like.” Ethanol and chloroform are common solutions for DOPE; they line up with DOPE’s oil-loving nature and break apart those tails, making the molecules move freely.
Researchers have run controlled experiments on this topic. The Merck Index and peer-reviewed journals report that DOPE shows high solubility in chloroform or ethanol. These solvents allow scientists to create thin lipid films, efficiently encapsulate drugs, or prepare delivery vehicles for therapeutics without leaving undissolved particles.
Solubility isn’t just a technical detail. I remember working in a biochemistry lab trying to load DOPE into a liposome. We wasted hours because we tried mixing it straight into water—ended with clumps and wasted materials. Only after switching to chloroform did the process move forward smoothly. In medicine, poorly soluble lipids sabotage progress, leading to unreliable dosing or unpredictable drug release.
Beyond the lab, this solubility decides which manufacturing techniques get used in food, cosmetics, and pharmacy. For people making nanoparticles or liposomal formulations, ignoring proper solubility means money down the drain.
The world pushes for safer, greener chemistry. Ethanol offers a less toxic option compared to other organic solvents, showing up more often in pharmaceutical-grade processes. Working toward solvent-free or water-compatible formulations could lower environmental impacts, but this usually needs clever workarounds: surfactants, high-shear mixing, or microfluidic methods.
Staying updated on solubility properties with DOPE isn’t just about following instructions. It boils down to reliable products, lab safety, and environmental responsibility. Factoring these lessons into design and formulation saves headaches and real cash—both in the lab and out in the world.
Handling DOPE, or dioleoylphosphatidylethanolamine, stirs up a lot of concern during storage and transport. This isn’t just a matter of red tape or checking boxes—one little mistake can ruin weeks of hard work. I’ve spent a fair share of time in labs, and the best lesson I learned: don’t trust fate when it comes to lipids.
DOPE really doesn’t like heat, light, and air. Even on a solid shelf, left in a regular room, DOPE starts to break down. Hydrolytic degradation and oxidation cause big trouble, leading to changes in its physical and chemical nature. Once breakdown kicks in, it’s not so easy to reverse. We’re not just talking about losing potency—compromised DOPE can transform your most careful prep into a waste of time and budget.
Every experienced chemist learns this trick fast: keep DOPE cold. I keep it in the deep freeze (about –20°C, sometimes even lower for long-term storage). If you leave it in the fridge, it won’t last as long, especially after opening the container. DOPE that seems fine can degrade fast, almost unnoticed, if temperature rises even a little in a crowded freezer or if it’s left out too long during prep.
Oxygen works against DOPE from the moment the bottle opens. Tight containers, ideally with nitrogen flushing, stop oxygen from sneaking in. I’ve used glass vials with tight PTFE-lined caps and watched coworkers pay for cheap lids—those don’t seal well. Each time you open a bottle, gas rushes in. Good practice means divvying up the powder into smaller aliquots, then only thawing one at a time. This wastes less and keeps the rest safe.
Many forget that fluorescent bulbs hit DOPE hard. Too much light triggers oxidation. Amber glass gives some protection, but a dark storage drawer gives even better peace of mind. In my setup, everything stays wrapped in foil and tucked far from sun or office lights. The extra step saves endless headaches with suspicious results later on.
DOPE and moisture do not mix. Humid air drifts in each time the lid comes loose, and micrograms of water set off hydrolysis. Keeping desiccants in with the container helps a lot. Silica gel or molecular sieves show big results over long months. You really notice the difference when you compare to powder pulled from a forgotten, damp cupboard.
Academia or industry, the lesson echoes everywhere. Reliable lipids support important research—from making liposomes for drug delivery to studying cell membranes. The more time and cash spent, the more crucial it gets to double down on storage practices. The cost of doing things right is far less than wrecking an experiment or triggering a recall. Real investment shows not in fancy refrigerators, but in routine staff training, smart lab design, and a culture where people care about specifics.
Careful temperature controls, oxygen-smart containers, dry and dark spaces—these steps don’t require advanced technology. They require patience, some discipline, and the willingness to learn from those quiet moments when something didn’t last as long as it should have. Good science and smart industry both rely on paying attention to these basics, again and again.
Looking through catalogs or datasheets for dioleoylphosphatidylethanolamine (DOPE), you might spot purity values circling around 98% or even as high as 99%. For folks working in research labs, the push for high purity comes from the need for reproducibility and safety. Impurities can mean trouble: background signals, strange results, or damaged cell cultures. When a supplier marks their DOPE at "≥98% by TLC" or "HPLC purity ≥99%," these distinctions matter. Thin-layer chromatography (TLC) gives a rough snapshot, but high-performance liquid chromatography (HPLC) can catch more nuanced differences, flagging tiny traces of unwanted bits. If you checked a certificate of analysis, you’d spot the actual batch purity, which usually meets or slightly beats the promised number, thanks to modern purification methods.
Working with lipids like DOPE always brings hurdles. The process of extracting and refining these molecules from egg yolk or soybeans takes solid lab skill and up-to-date tech. Oxygen can turn unsaturated lipid tails into peroxides or other breakdown products. Water finds its way into the mix, no matter the precautions. Even top-tier producers face these challenges. Anyone who’s opened a fresh vial and noticed even a sliver of cloudiness or an odd whiff understands the problem. The closer to 100% you try to get, the steeper the expense and complexity become. Most end-users strike a balance here, opting for 98–99% because anything much higher drives up cost with little improvement in results for many common applications.
For cell culture and drug delivery experiments, every percent of purity might save a week of troubleshooting. One unexpected side effect or batch-to-batch inconsistency sends you back to the drawing board. Experience has taught me never to skimp on this step; a small savings on lower-grade DOPE rarely pays off after factoring in failed reactions and repeat orders. Even in industries like vaccine formulation or gene therapy, there’s a strong argument for going straight to the highest available purity. Lives and big investments ride on the outcomes, so every impurity is a risk not worth taking.
The best move starts with picking a reliable supplier—one that regularly updates certificates of analysis, tracks batch retention samples, and encourages open communication with their technical team. Checking the origin (synthetic, plant-derived, or animal-derived) and looking for signs of added antioxidants or stabilizers helps prevent nasty surprises. Storing DOPE under argon or nitrogen, in amber vials within low-temperature freezers, keeps oxidation from creeping in over time. Getting familiar with TLC or HPLC readouts gives a clearer view of what’s in your dropper before it touches your experiment.
The future will bring cheaper, more sustainable options as bioengineering and automated synthesis improve. For now, anyone working with DOPE should hold out for 98–99% and run their own checks now and then. Better purity isn’t just about numbers—it shields the workdays, budgets, and discoveries built around those small vials.
| Names | |
| Preferred IUPAC name | (2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propyl (9Z,12Z)-octadeca-9,12-dienoate |
| Other names |
dioleoylphosphatidylethanolamine DOPE 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine 1,2-dioleoyl-phosphatidylethanolamine 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine Oleyloleylphosphatidylethanolamine |
| Pronunciation | /ˈdaɪ.əˌlɔɪl.sn.ɡlɪˌsɪə.roʊ.θriː.fɒs.foʊˌɛθ.əˈnəʊ.ləˌmin/ |
| Identifiers | |
| CAS Number | ["4004-05-1"] |
| Beilstein Reference | 1710868 |
| ChEBI | CHEBI:86154 |
| ChEMBL | CHEMBL3313877 |
| ChemSpider | 82853 |
| DrugBank | DB11196 |
| ECHA InfoCard | 03cc3f1e-fb98-4992-92fa-0037db6b6f74 |
| Gmelin Reference | 66318 |
| KEGG | C04230 |
| MeSH | D015425 |
| PubChem CID | 446429 |
| RTECS number | RQJ6994520 |
| UNII | Y41JS2NL5B |
| UN number | Not regulated |
| Properties | |
| Chemical formula | C41H78NO8P |
| Molar mass | 744.052 g/mol |
| Appearance | White to off-white solid |
| Odor | odourless |
| Density | 0.982 g/mL |
| Solubility in water | Insoluble |
| log P | log P: -2.7 |
| Vapor pressure | Negligible |
| Acidity (pKa) | pKa around 9.0 |
| Basicity (pKb) | 7.57 |
| Magnetic susceptibility (χ) | -67.7×10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.474 |
| Viscosity | Viscous oil |
| Dipole moment | 5.16 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 1645.8 J·mol⁻¹·K⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -16139.8 kJ/mol |
| Hazards | |
| Main hazards | Causes serious eye irritation. Causes skin irritation. May cause respiratory irritation. |
| GHS labelling | Not a hazardous substance or mixture. |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H319: Causes serious eye irritation. |
| Precautionary statements | Wash thoroughly after handling. Wear protective gloves/protective clothing/eye protection/face protection. |
| NFPA 704 (fire diamond) | NFPA 704: 0-1-0 |
| Flash point | >100 °C (212 °F) |
| NIOSH | Not listed |
| PEL (Permissible) | No OSHA PEL assigned |
| REL (Recommended) | 0.1-0.2 mg/mL |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
1,2-Dioleoyl-sn-glycero-3-phosphocholine (DOPC) 1,2-Dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) 1,2-Dioleoyl-sn-glycero-3-phosphoglycerol (DOPG) 1,2-Dioleoyl-sn-glycero-3-phosphate (DOPA) 1,2-Dioleoyl-sn-glycero-3-phosphoinositol (DOPE-PI) |
